VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
TRDAEntrada Therapeutics, Inc.
$7.07$274M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksTRDAPrice History

TRDA logoEntrada Therapeutics, Inc. (TRDA) Stock Price History

Historical prices from 2021 to 2026

$7.07-0.02  (-0.28%)close Jun 22
Returns
1M
+20.4%
3M
-40.3%
YTD
-29.5%
1Y
+0.9%
3Y
-22.1%
5Y
-21.6%
ATH$36.85Nov 2021-80.8%
ATL$4.93Aug 2025pre-split
Avg Vol (50D)412K/ day
52-Week Range$4.93 — $16.45
LowCurrent: $7.07High

Loading 10-year price history...

TRDA Historical Performance

1 YearTotal Return
+0.9%
Price: +0.9%
3 YearsTotal Return
-52.8%
CAGR: -22.1%
Price: -52.8%
5 YearsTotal Return
-70.4%
CAGR: -21.6%
Price: -70.4%
YTD
-29.5%

TRDA Annual Returns

Year-by-year price performance · 2021–2026

Best+14.0%2024
Worst-41.1%2025
Up years3/6
2021-28.5%
2022-20.1%
2023+12.3%
2024+14.0%
2025-41.1%
2026+18.7%
2021 annual price return
-28.5%
2022 annual price return
-20.1%
2023 annual price return
+12.3%
2024 annual price return
+14.0%
2025 annual price return
-41.1%
2026 annual price return
+18.7%
LessMore
Alpha vs S&P 500
1Y-24.1%
3Y-42.7%
5Y-34.7%

Price returns only.

Download Historical Data

1,165 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

TRDA Stock Price Trajectory (2021–2026)

As of June 23, 2026, Entrada Therapeutics, Inc. (TRDA) trades at $7.07, representing a +0.9% return over the past year. The stock has delivered a -70.4% total return over five years (-21.6% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $36.85 on November 18, 2021. From this peak, TRDA has corrected -80.8%, currently trading 25% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers ARWR (+423.8% 1Y), NTLA (+63.2% 1Y), and BEAM (+100.9% 1Y), TRDA has underperformed the peer group average. Compare TRDA vs ARWR →

TRDA Historical Price Data · from 2021

Rows 1–50 of 1,165
Date Open High Low Close Volume Change %
2026-06-227.167.376.917.07274K-0.28%
2026-06-186.997.216.767.09314K+4.11%
2026-06-176.507.066.506.81193K+4.77%
2026-06-166.426.626.376.50166K-1.14%
2026-06-156.596.726.396.58191K+1.78%
2026-06-126.316.516.196.46172K+2.38%
2026-06-116.366.395.766.31338K+5.70%
2026-06-106.436.505.955.97269K-6.28%
2026-06-096.396.616.156.37167K+1.76%
2026-06-086.386.496.136.26237K-1.73%
2026-06-056.997.106.346.37187K-9.00%
2026-06-046.687.086.577.00235K+6.38%
2026-06-036.756.806.486.58240K-0.90%
2026-06-026.806.806.506.64271K-3.91%
2026-06-016.987.136.746.91272K-2.26%
2026-05-296.857.116.757.07270K+3.67%
2026-05-286.666.916.596.82306K+2.87%
2026-05-276.606.866.536.63423K-1.04%
2026-05-266.616.846.336.70511K+2.13%
2026-05-226.516.766.516.56366K+3.96%
2026-05-216.046.355.936.31366K+4.47%
2026-05-205.706.075.706.04437K+6.90%
2026-05-195.865.865.635.65377K-4.07%
2026-05-186.366.395.835.89433K-7.68%
2026-05-156.666.766.316.38327K-6.59%
2026-05-147.257.416.356.83779K-6.69%
2026-05-137.027.336.787.32670K+2.81%
2026-05-127.007.526.937.121.24M+1.71%
2026-05-116.887.366.827.00790K+2.52%
2026-05-086.526.876.016.831.19M-0.32%
2026-05-076.707.895.736.854.11M-57.27%
2026-05-0615.6816.4515.2616.03403K+1.78%
2026-05-0515.8216.1914.8115.75397K-0.25%
2026-05-0414.4015.8414.4015.79424K+8.90%
2026-05-0113.4614.5613.1114.50319K+7.41%
2026-04-3012.7113.5812.5613.50582K+6.13%
2026-04-2912.7512.9912.4112.72141K-1.32%
2026-04-2813.0313.2812.6212.89135K-0.54%
2026-04-2712.5313.1012.5312.96138K+2.61%
2026-04-2412.8313.0912.1812.63160K-1.41%
2026-04-2313.0913.2412.4512.81163K-1.84%
2026-04-2213.1813.2312.8213.05129K-0.15%
2026-04-2113.5513.5513.0213.0796K-3.61%
2026-04-2013.9113.9713.5113.56132K-3.07%
2026-04-1713.8014.0413.6013.99111K+3.17%
2026-04-1613.9314.0413.4113.56154K-3.07%
2026-04-1513.8814.2413.7413.9979K-0.29%
2026-04-1413.9314.4913.9314.0380K+1.01%
2026-04-1313.5413.9613.3413.8990K+2.89%
2026-04-1014.0414.2013.3713.50212K-3.91%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

TRDA — Frequently Asked Questions

Quick answers to the most common questions about buying TRDA stock.

How has TRDA stock performed recently?

TRDA returned +0.9% over the past year, beating its 5-year annualized CAGR of -21.6%. The stock trades below its 200-day moving average, confirming the uptrend.

What is TRDA's all-time high price?

Entrada Therapeutics, Inc. reached $36.85 on 2021-11-18. The 52-week high is $16.45. Current 1-year return of +0.9% places the stock closer to historical peaks.

Where can I download TRDA historical price data?

This page provides TRDA daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.

389 data points · sampled from 1,165